FDA — authorised 25 September 2006
- Application: ANDA077351
- Marketing authorisation holder: PERRIGO R AND D
- Status: supplemented
FDA authorised PEP on 25 September 2006
Yes. FDA authorised it on 25 September 2006.
PERRIGO R AND D holds the US marketing authorisation.